Skip to content

Evaluating the Effectiveness of Remote Ischemic Preconditioning (RIPC) in Improving Clinical Indicators and Therapeutic Outcomes in Hospitalized Patients with Respiratory Disorders

Evaluating the Effectiveness of Remote Ischemic Preconditioning (RIPC) in Improving Clinical Indicators and Therapeutic Outcomes in Hospitalized Patients with Respiratory Disorders at Intensive Care Unit

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250901067083N1
Enrollment
40
Registered
2025-09-09
Start date
2025-09-23
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Acute respiratory distress syndrome. Condition 2: Chronic obstructive pulmonary disease with (acute) exacerbation. Condition 3: Asthma. Condition 4: Bronchopneumonia, unspecified organism. Acute respiratory distress syndrome Chronic obstructive pulmonary disease with (acute) exacerbation Asthma Bronchopneumonia, unspecified organism

Interventions

Intervention 1: Intervention group: The intervention group, upon admission to the intensive care unit on the first day of hospitalization, will undergo remote ischemic preconditioning (RIPC) twice, wi

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Admission to the intensive care unit due to acute respiratory disorder Relatively stable hemodynamic status (Mean Arterial Pressure = 65 mmHg without the need for vasopressors or at low doses) Filling out an informed consent

Exclusion criteria

Exclusion criteria: Presence of active disease or severe skin damage to the upper limb (open wound, gangrene, infection, recent trauma) History of surgery or severe occlusion of upper extremity arteries Severe heart failure (Left Ventricle Ejection Fraction (LVEF ) < 30% or cardiogenic shock) End-stage Kidney disease Thrombophilia or anticoagulant use with high risk of bleeding Pregnancy Concurrent participation in other clinical studies Length of hospitalization less than 7 days

Design outcomes

Primary

MeasureTime frame
Respiratory Index. Timepoint: First, third, and seventh day of hospitalization. Method of measurement: Calculation via formula based on patient laboratory results.;Ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen. Timepoint: First, third, and seventh day of hospitalization. Method of measurement: Calculation based on patient laboratory results.

Secondary

MeasureTime frame
Length of stay in the intensive care unit. Timepoint: At discharge. Method of measurement: Based on the patient's records.;Intubation. Timepoint: At discharge. Method of measurement: Based on the patient's record indicating the need for intubation.;Clinical outcome. Timepoint: At discharge. Method of measurement: Based on the patient's record of recovery or death.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Farrokhpour

Iran University of Medical Sciences

farrokhpour.m@iums.ac.ir+98 21 8214 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026